Testa Challenge is an opportunity to verify bio-process technology

Featured Video Play Icon

We welcome all kind of innovative solutions that have the potential to meet the future technology needs within bio-production. Some examples in the area of technology include sensors, separation technology, pumps, etc. and within the digital/data segment, some examples include cloud solutions, VR / AR, AI, data transfer, modeling, automation, smart laboratory tools, etc.
Projects and companies from the technology/digital segments are invited to integrate, test and witness their innovation within a sponsored production workflow at Testa Center. Alongside the production process, participants will be supported by experts and have the possibility to experience their innovation hands on.

Testa Center is now a part of Cytiva

Testa Center Logo Purple

We are happy to announce that Testa Center is now part of Cytiva. We continue our operations as always, and are looking forward to working with you and our community of best-in-class companies in Life Sciences, Diagnostics and Environmental & Applied Solutions.

Testa Center precautions and policies – COVID-19

As the situation around COVID-19 progresses, we endeavor to keep our Testa Center offices and labs open at this time for important scientific work. We are working daily with our Crisis Response Teams to coordinate our efforts as a global company to find a balance between producing the critical medical equipment our customers need with …

Protein Science Facility visits Testa Center

Protein Science Facility

Protein Science Facility, offer services in protein production and provides access to infrastructure for Macromolecular X-ray crystallography (MX) and biophysical protein characterization. Their staff, Tomas Nyman, Elin Dunevall, Henry Ampah-Korsah, Emilia Strandback and Martin Moche all made the trip from Biomedicum and the department of Medical Biochemistry and Biophysics at Karolinska Institutet to learn more …

Project funding available during 2020 by VINNOVA

Vinnova Sweden's Innovation Agency

Maximum funding per project: 300 000 SEK
Required co-funding: 50% (for all entities, including universities).
Who can apply? The opening is available for academic researchers, SME and large companies.
How to apply? Proposals are welcome and will be evaluated on a continual basis. Please contact helena.stroberg@uppsalabio.com or kristin.hellman@uppsalabio.com

Rockwell Automation in Testa Center for Pharma 4.0

Rockwell automation

On the 11th of December we had the pleasure to welcome Felix Langkjaer, Martin Ohlsson, Peter Cullen with entourage, from Rockwell Automaton, for a meeting in Testa Center. Rockwell Automation an supplier of automation in a broad spectrum of industries. Testa Center is a flexible and open access bio-process R&D facility. Mixing these two in …

What is Testa Center?

Featured Video Play Icon

Academia, startups, companies and industry are all welcome to Testa Center – an open, non-profit, non-GMP, production-like facility and test-bed for education, innovation and proof-of-concept experiments on production processes for biological products. e.g. monoclonal antibodies, peptides and proteins. Access both equipment and expertise to go from lab bench scale to industrial scale of protein production …

Press release “A successful first year for Testa Center”

“Fifteen projects from Scandinavia have so far benefited from the technology and know-how available at Testa Center. Read full text Over the year we have had the pleasure to have a great variety of project in Testa Center! “The projects range from scale-up and purification activities, educational programs, and digital verification to GE Healthcare Life …

See Testa Center in stand #20 at Nordic Life Science Days 2019!

booth 20 on NLS days 2019

Want to meet Testa Center’s staff and discuss projects, instruments, innovation-hubs or similar? We are happy see you and welcome you to visit us in stand #20. Looking forward to see you at Nordic Life Science Days 2019! Dr. Lotta Ljungqvist, Testa Center CEO, holds the Official Opening Plenary Make sure to see and listen …

Lotta Ljungqvist receives the prestigious Biotech Builders’ 2019 Award

Lotta recives Biotech builders award

We are very proud to announce that Lotta Ljungqvist, President & CEO GE Nordics & CEO Testa Center at GE Healthcare received the Biotech Builders’ Award for 2019. According to Biotech Builders, the winner of the prestigious award is a person who embodies the entrepreneurial fundamentals, laying way for the future of the Swedish Life …

Scaling up the Value with Toleraniza

The Gothenburg based, Swedish biotech company Toleranzia AB entered Testa Center building in Uppsala with packages full of materials and hope. Their entrance represents an important national breakthrough for and an opportunity for Toleranzia to validate the manufacturing process for the drug candidate TOL2 and to provide further industrialization of the company itself. “I think …

Testa Center welcomes the SciAR Company to test AR/MR in Bio-process labs

The Finnish company Sciar Company ltd. creates software for Augmented Reality (AR) and Mixed Reality (MR) to take human errors out of the equation in Life Science laboratories. Testa Center, as a bridge between innovation, science and industry, could contribute to the development of their product. SciAR has a primary position twice: as a first …

GE to sell Bio-Pharma Business to Danaher

In an announcement on February 25, GE announced the proposed sale of parts of the current Life Sciences business to US-based Danaher Corporation. The transaction, is subject to customary closing conditions, including regulatory reviews and appropriate consultation processes, and is expected to be complete by 4Q 2019. Testa Center, as a non-profit company owned and operated by …

Uppsala University Master’s Students at Testa Center

The long-term collaboration agreement with Uppsala University and GE Healthcare gives not only researchers, but also students access to the equipment and specialized expertise at Testa Center. Now in December we are thrilled to have the first class of last-year students on the Master of Science programme in Molecular Biotechnology Engineering at Uppsala University at …

BioLamina first to arrive to Testa Center

The Swedish biotechnology company BioLamina was the first customer to run their project at Testa Center. BioLamina was founded in 2008 by Dr. Karl Tryggvason and his son Dr. Kristian Tryggvason, and today the company has grown into a business with global presence and about 20 employees. BioLamina develops, manufactures and distributes premium cell culture …